EVANSTON, Ill., May 7 /PRNewswire-FirstCall/ -- Northfield Laboratories
Inc. (Nasdaq: NFLD), a leading developer of an oxygen-carrying blood
substitute for trauma and elective surgery situations, today announced that
Richard DeWoskin, Chief Executive Officer, and Dr. Steven A. Gould, M.D.,
President, are scheduled to speak at the Health Care 2002, Deutsche Banc Alex.
Brown Healthcare Conference in Baltimore on Thursday, May 9, at 11:00 a.m.
(EDT).
This presentation is being webcast and can be accessed on line at
Northfield Laboratories' web site, http://www.northfieldlabs.com . The webcast is
also being distributed through Deutsche Banc Alex. Brown's website,
http://www.db.com/conferences .
About the Company
Northfield Laboratories, founded in 1985, is a leading developer of an
oxygen-carrying blood substitute. Its product, PolyHeme, is the only blood
substitute undergoing clinical trials that has been tested at large enough
dosages to be considered a substitute for acute blood loss in trauma and
surgical settings. As a result of the process used to manufacture the blood
substitute, essentially a solution of polymerized hemoglobin, PolyHeme has a
longer shelf life than blood, requires no cross matching and does not transmit
disease.
Visit the Northfield website at: http://www.northfieldlabs.com
SOURCE Northfield Laboratories Inc.
 back to top
Related links:
http://www.db.com/conferences
http://www.northfieldlabs.com
CONTACT:
Richard DeWoskin, Chief Executive Officer of
Northfield Laboratories, +1-847-864-3500, or Investors, Bill
Schmidle, +1-312-640-6753, or Media, Cindy Martin,
+1-312-640-6741, both of FRB Weber Shandwick
|
